-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Upgrades Oscar Health to Overweight, Raises Price Target to $25

Benzinga·11/26/2025 13:04:21
Listen to the news
Piper Sandler analyst Jessica Tassan upgrades Oscar Health (NYSE:OSCR) from Neutral to Overweight and raises the price target from $13 to $25.